Methodologies to investigate intracellular barriers for nucleic acid delivery in non-viral gene therapy

被引:40
|
作者
Vermeulen, Lotte M. P. [1 ,2 ]
Brans, Toon [1 ,2 ]
De Smedt, Stefaan C. [1 ]
Remaut, Katrien [1 ]
Braeckmans, Kevin [1 ,2 ]
机构
[1] Univ Ghent, Fac Pharmaceut Sci, Lab Gen Biochem & Phys Pharm, Ottergemsesteenweg 460, Ghent, Belgium
[2] Univ Ghent, Fac Pharmaceut Sci, Ctr Nano & Biophoton, Ottergemsesteenweg 460, Ghent, Belgium
基金
欧洲研究理事会;
关键词
Nanomaterials; Biological barriers; Nucleic acids; Gene therapy; Drug delivery; Nanomedicine; ENHANCED RAMAN-SPECTROSCOPY; HIGH-THROUGHPUT QUANTIFICATION; SCANNING-ELECTRON-MICROSCOPY; QUANTUM-DOT NANOPARTICLES; SINGLE-PARTICLE TRACKING; PLASMA-MASS SPECTROMETRY; MEDIATED SIRNA DELIVERY; ENDOSOMAL ESCAPE; CELLULAR UPTAKE; GOLD NANOPARTICLES;
D O I
10.1016/j.nantod.2018.06.007
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A plethora of biological barriers, intended to defend tissues and cells against external influences, stand in the way of efficient nucleic acid delivery by non-viral nanoplexes. Even when nanoplexes successfully evade extracellular barriers and reach their target cell, many intracellular barriers remain to be conquered. These include overcoming the plasma membrane, evading endosomal compartmentalization, and in some cases crossing the nuclear envelope. At the same time, exocytosis, autophagy and cytoplasmic degradation of the cargo should be avoided. Currently, there is a growing appreciation that the interaction of nanoplexes with these barriers should be understood in detail in order to rationally design a second generation of non-viral nanoplexes, capable of overcoming these many hurdles. Studying intracellular biobarriers is, however, quite challenging and specialized methods are constantly being developed. In this review, we present an overview of established as well as emerging techniques and assays that are currently available to the experimentalist to study nanoplex-barrier interaction, with a focus on quantitative methods. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:74 / 90
页数:17
相关论文
共 50 条
  • [41] Oral non-viral gene delivery for applications in DNA vaccination and gene therapy
    Farris, Eric
    Heck, Kari
    Lampe, Anna T.
    Brown, Deborah M.
    Ramer-Tait, Amanda E.
    Pannier, Angela K.
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2018, 7 : 51 - 57
  • [42] Non-viral nanocarriers for intracellular delivery of microRNA therapeutics
    Bai, Zhiman
    Wei, Jing
    Yu, Changmin
    Han, Xisi
    Qin, Xiaofei
    Zhang, Chengwu
    Liao, Wenzhen
    Li, Lin
    Huang, Wei
    JOURNAL OF MATERIALS CHEMISTRY B, 2019, 7 (08) : 1209 - 1225
  • [43] Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery
    Grijalvo, Santiago
    Puras, Gustavo
    Zarate, Jon
    Sainz-Ramos, Myriam
    Qtaish, Nuseibah A. L.
    Lopez, Tania
    Mashal, Mohamed
    Attia, Noha
    Diaz Diaz, David
    Pons, Ramon
    Fernandez, Eduardo
    Luis Pedraz, Jose
    Eritja, Ramon
    PHARMACEUTICS, 2019, 11 (02)
  • [44] AIChE journal highlight: Non-viral gene delivery for cancer therapy
    1600, American Institute of Chemical Engineers (113):
  • [45] Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy
    Wang, Kai
    Huang, Qian
    Qiu, Fuming
    Sui, Meihua
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (35) : 4118 - 4136
  • [46] Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
    Van de Vyver, Thijs
    De Smedt, Stefaan C.
    Raemdonck, Koen
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 181
  • [47] Non-viral gene transfer in gene therapy
    Zhdanov, RI
    Kutsenko, NG
    Fedchenko, VI
    VOPROSY MEDITSINSKOI KHIMII, 1997, 43 (01): : 3 - 12
  • [48] Non-viral Gene Therapy for Osteoarthritis
    Uzieliene, Ilona
    Kalvaityte, Ursule
    Bernotiene, Eiva
    Mobasheri, Ali
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 8
  • [49] Microfluidic Methods for Non-Viral Gene Delivery
    Lai, Wing-Fu
    CURRENT GENE THERAPY, 2015, 15 (01) : 55 - 63
  • [50] Key issues in non-viral gene delivery
    Pouton, CW
    Seymour, LW
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (01) : 3 - 19